期刊文献+

Toll样受体4在动脉粥样硬化中的作用研究进展 被引量:10

下载PDF
导出
摘要 Toll样受体尤其是Toll样受体4作为介导天然免疫反应的一类跨膜受体蛋白在动脉粥样硬化进程中的作用日益引起关注,本文就其结构、配体及其在动脉粥样硬化各阶段作用及动脉粥样硬化免疫学治疗现状作一概述。
出处 《中国动脉硬化杂志》 CAS CSCD 2008年第1期78-80,共3页 Chinese Journal of Arteriosclerosis
  • 相关文献

参考文献25

  • 1Hansson G K. Inflammation, atherosclerosis, and coronary artery disease[J]. New Engl J Med, 2005,352(16):1685-695.
  • 2Sahroe I, Read RC, Whyte MK, et al. Ton-like receptors in health and disease: complex questions remain [J]. J Immunol, 2003, 171 (4): 1630-635.
  • 3McGettrick AF, O'Neill LA. The expanding family of MyD88-like adaptors in Toll-like receptor signal transduction [ J]. Mol Immunol, 2004, 41 (6-7): 577-582.
  • 4Walton KA, Hsieh X, Gharavi N, et al. Receptors involved in the oxidized 1- palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine-mediated synthesis of interleukin-8. A role for Toll-like receptor 4 and a glycosylphosphatidylinositol-anchored protein [ J]. J Biol Chem, 2003, 278 ( 32 ) : 29 661-666.
  • 5Stol LL, Denning GM, Li WG, et al. Regulation of endotoxin-induced proinflammatory activation in human coronary artery cells: expression of functional membrane-bound CD14 by human coronary artery smooth muscle cells [ J]. J Immunol, 2004, 173(2): 1 336-343.
  • 6Hollestelle SC, De Vries MR, Van Keulen JK, et al. Toll-like receptor 4 is involved in outward arterial remodeling [ J]. Circulation, 2004, 109(3) : 393- 398.
  • 7Boekholdt SM, Agema WR, Peters RJ, et al. Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events [J]. Circulation, 2003, 107 (19): 2 416-421.
  • 8Xu Q. Infections, beat shock proteins, and atherosclerosis [J]. Current Opin Cardiol, 2003, 18 (4): 245-252.
  • 9Vabulas RM, Ahmad-Nejad P, da Costa C, et al. Endoeytosed use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells [ J]. J Biol Chem, 2001, 276 ( 33 ) : 31 332-339.
  • 10Punturieri A, Alviani RS, Polak T, et al. Specific engagement of TLR4 or TLR3 does not lead to IFN-beta-mediated innate signal amplification and STAT1 phosphorylation in resident murine alveolar macrophages[J]. J Immunol, 2004, 173(2):1033-042.

二级参考文献23

  • 1杨彬,马颖哲,马岩,刘坤.基质金属蛋白酶与动脉粥样硬化[J].吉林大学学报(医学版),2004,30(5):831-834. 被引量:4
  • 2Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med, 1999, 340: 115-126
  • 3Ridker PM, Hennekens CH, Stampfer MJ. Plasma concentration of soluble intercellular adhesion molecule-1 and risks of future myocardial infarction in apparently healthy men. Lancet, 1998, 351: 88-92
  • 4Hamilos DL, Leuny DY, Wood R. Eosinophil inflitration in nonallergenic chronic hyperplastil sinusitis with nasal polyposis(CHS/MP) is associated with endothelial VCAM-1upregulation and expression of TNF-α. Am J Respir Cell Mol Biol, 1996, 15: 443-450
  • 5Mullol J, Xaubet A, Loper E. Eosinophil activation by epithelial cells of the respiratory mucosa,comparative study of nomalmucosa and inflammatory mucosa. Med Clin Barc, 1997, 31 (1): 6-11
  • 6Ross R. The pathogenesis of atherosclerosis:a perspective for the 1990s. Nature, 1993, 362 (6423): 801
  • 7O'Brien KD, Allen MD, Mcdonald TO. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plagues:implications for.The mode of progression of advanced coronary atherosclerosis. J Clin Invest, 1993, 92 (2): 945-951
  • 8Cybusky MI, Fries JN, Williams AJ. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherosclerosis. Science, 1991, 251: 788-795
  • 9Tingsgaard PK, Larsen PL, Bock T. Expression of intercellular adhesion molecule-1 on the vascular endothelium in nasal polyps before,during and after topical glucocorticoid treatment. Acta Otolaryngol, 1998, 118 (3): 404-408
  • 10Costa JJ, Matossian K, Resnick MB. Human eosinophils can express the cytokinase tumor necrosis factor-alpha and macrophage inflammatory protein alpha. J Clin Invest, 1993, 91: 2 673-684

共引文献57

同被引文献139

引证文献10

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部